{
  "input": {
    "mode": "execute_actions",
    "query": {
      "entity": "Gastrointestinal epithelial barrier disorders",
      "relation": "indication"
    },
    "items": [
      {
        "hypothesis_id": "H1",
        "graph_actions": [
          {
            "type": "add_mechanism_link",
            "from": "Infliximab",
            "via": [],
            "to": "Gastrointestinal epithelial barrier disorders",
            "success_criteria": "验证其疗效与安全性的具体数据",
            "assignee": "Proponent"
          }
        ]
      },
      {
        "hypothesis_id": "H2",
        "graph_actions": [
          {
            "type": "add_mechanism_link",
            "from": "Mesalazine",
            "via": [],
            "to": "Gastrointestinal epithelial barrier disorders",
            "success_criteria": "验证其疗效与安全性的具体数据",
            "assignee": "Proponent"
          }
        ]
      },
      {
        "hypothesis_id": "H3",
        "graph_actions": [
          {
            "type": "add_mechanism_link",
            "from": "Budesonide",
            "via": [],
            "to": "Gastrointestinal epithelial barrier disorders",
            "success_criteria": "验证其疗效与安全性的具体数据",
            "assignee": "Proponent"
          }
        ]
      },
      {
        "hypothesis_id": "H4",
        "graph_actions": [
          {
            "type": "add_mechanism_link",
            "from": "Azathioprine",
            "via": [],
            "to": "Gastrointestinal epithelial barrier disorders",
            "success_criteria": "验证其疗效与安全性的具体数据",
            "assignee": "Proponent"
          }
        ]
      },
      {
        "hypothesis_id": "H5",
        "graph_actions": [
          {
            "type": "add_mechanism_link",
            "from": "Adalimumab",
            "via": [],
            "to": "Gastrointestinal epithelial barrier disorders",
            "success_criteria": "验证其疗效与安全性的具体数据",
            "assignee": "Proponent"
          }
        ]
      },
      {
        "hypothesis_id": "H6",
        "graph_actions": [
          {
            "type": "add_mechanism_link",
            "from": "Tacrolimus",
            "via": [],
            "to": "Gastrointestinal epithelial barrier disorders",
            "success_criteria": "验证其疗效与安全性的具体数据",
            "assignee": "Proponent"
          }
        ]
      },
      {
        "hypothesis_id": "H7",
        "graph_actions": [
          {
            "type": "add_mechanism_link",
            "from": "Natalizumab",
            "via": [],
            "to": "Gastrointestinal epithelial barrier disorders",
            "success_criteria": "验证其疗效与安全性的具体数据",
            "assignee": "Proponent"
          }
        ]
      },
      {
        "hypothesis_id": "H8",
        "graph_actions": [
          {
            "type": "add_mechanism_link",
            "from": "Vedolizumab",
            "via": [],
            "to": "Gastrointestinal epithelial barrier disorders",
            "success_criteria": "验证其疗效与安全性的具体数据",
            "assignee": "Proponent"
          }
        ]
      },
      {
        "hypothesis_id": "H9",
        "graph_actions": [
          {
            "type": "add_mechanism_link",
            "from": "Methotrexate",
            "via": [],
            "to": "Gastrointestinal epithelial barrier disorders",
            "success_criteria": "验证其疗效与安全性的具体数据",
            "assignee": "Proponent"
          }
        ]
      },
      {
        "hypothesis_id": "H10",
        "graph_actions": [
          {
            "type": "add_mechanism_link",
            "from": "Ustekinumab",
            "via": [],
            "to": "Gastrointestinal epithelial barrier disorders",
            "success_criteria": "验证其疗效与安全性的具体数据",
            "assignee": "Proponent"
          }
        ]
      },
      {
        "hypothesis_id": "H11",
        "graph_actions": [
          {
            "type": "add_mechanism_link",
            "from": "5-Aminosalicylic Acid",
            "via": [],
            "to": "Gastrointestinal epithelial barrier disorders",
            "success_criteria": "验证其疗效与安全性的具体数据",
            "assignee": "Proponent"
          }
        ]
      },
      {
        "hypothesis_id": "H12",
        "graph_actions": [
          {
            "type": "add_mechanism_link",
            "from": "Oral Corticosteroids",
            "via": [],
            "to": "Gastrointestinal epithelial barrier disorders",
            "success_criteria": "验证其疗效与安全性的具体数据",
            "assignee": "Proponent"
          }
        ]
      }
    ],
    "tegraph_snapshot": {
      "nodes": [
        {
          "id": "drug_infliximab",
          "type": "Drug",
          "label": "Infliximab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_mesalazine",
          "type": "Drug",
          "label": "Mesalazine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_budesonide",
          "type": "Drug",
          "label": "Budesonide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_azathioprine",
          "type": "Drug",
          "label": "Azathioprine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_adalimumab",
          "type": "Drug",
          "label": "Adalimumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_tacrolimus",
          "type": "Drug",
          "label": "Tacrolimus",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_natalizumab",
          "type": "Drug",
          "label": "Natalizumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_vedolizumab",
          "type": "Drug",
          "label": "Vedolizumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_methotrexate",
          "type": "Drug",
          "label": "Methotrexate",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_ustekinumab",
          "type": "Drug",
          "label": "Ustekinumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_5_aminosalicylic_acid",
          "type": "Drug",
          "label": "5-Aminosalicylic Acid",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_oral_corticosteroids",
          "type": "Drug",
          "label": "Oral Corticosteroids",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "Phenotype_Gastrointestinal_disorder",
          "type": "Phenotype",
          "label": "Gastrointestinal epithelial barrier disorders",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_infliximab",
          "type": "Drug",
          "label": "Infliximab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_mesalazine",
          "type": "Drug",
          "label": "Mesalazine",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_budesonide",
          "type": "Drug",
          "label": "Budesonide",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_azathioprine",
          "type": "Drug",
          "label": "Azathioprine",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adalimumab",
          "type": "Drug",
          "label": "Adalimumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_tacrolimus",
          "type": "Drug",
          "label": "Tacrolimus",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_natalizumab",
          "type": "Drug",
          "label": "Natalizumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_vedolizumab",
          "type": "Drug",
          "label": "Vedolizumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_methotrexate",
          "type": "Drug",
          "label": "Methotrexate",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ustekinumab",
          "type": "Drug",
          "label": "Ustekinumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_aminosalicylic_acid",
          "type": "Drug",
          "label": "5-Aminosalicylic Acid",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_oral_corticosteroids",
          "type": "Drug",
          "label": "Oral Corticosteroids",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot",
          "type": "Target",
          "label": "OffTarget",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp",
          "type": "Pathway",
          "label": "RiskPathway",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv",
          "type": "Phenotype",
          "label": "AdversePhenotype",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "H1",
          "type": "Hypothesis",
          "label": "Infliximab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H2",
          "type": "Hypothesis",
          "label": "Mesalazine",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H3",
          "type": "Hypothesis",
          "label": "Budesonide",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H4",
          "type": "Hypothesis",
          "label": "Azathioprine",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H5",
          "type": "Hypothesis",
          "label": "Adalimumab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H6",
          "type": "Hypothesis",
          "label": "Tacrolimus",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H7",
          "type": "Hypothesis",
          "label": "Natalizumab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H8",
          "type": "Hypothesis",
          "label": "Vedolizumab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H9",
          "type": "Hypothesis",
          "label": "Methotrexate",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H10",
          "type": "Hypothesis",
          "label": "Ustekinumab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H11",
          "type": "Hypothesis",
          "label": "5-Aminosalicylic Acid",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H12",
          "type": "Hypothesis",
          "label": "Oral Corticosteroids",
          "attrs": {
            "agent": "PI"
          }
        }
      ],
      "edges": [
        {
          "source": "drug_infliximab",
          "target": "Phenotype_Gastrointestinal_disorder",
          "relation": "supports",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "已知用于治疗的药物，具备良好疗效"
        },
        {
          "source": "drug_mesalazine",
          "target": "Phenotype_Gastrointestinal_disorder",
          "relation": "supports",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "相关文献支持其用于此表型"
        },
        {
          "source": "drug_budesonide",
          "target": "Phenotype_Gastrointestinal_disorder",
          "relation": "supports",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "具有相似用途，临床应用常见"
        },
        {
          "source": "drug_azathioprine",
          "target": "Phenotype_Gastrointestinal_disorder",
          "relation": "supports",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "用于 autoimmune diseases，有潜在益处"
        },
        {
          "source": "drug_adalimumab",
          "target": "Phenotype_Gastrointestinal_disorder",
          "relation": "supports",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "针对炎症性疾病的靶向药物"
        },
        {
          "source": "drug_tacrolimus",
          "target": "Phenotype_Gastrointestinal_disorder",
          "relation": "supports",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "免疫抑制剂，可能有治疗潜力"
        },
        {
          "source": "drug_natalizumab",
          "target": "Phenotype_Gastrointestinal_disorder",
          "relation": "supports",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "相关研究显示其潜在效果"
        },
        {
          "source": "drug_vedolizumab",
          "target": "Phenotype_Gastrointestinal_disorder",
          "relation": "supports",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "靶向治疗特定类型的疾病"
        },
        {
          "source": "drug_methotrexate",
          "target": "Phenotype_Gastrointestinal_disorder",
          "relation": "supports",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "在自身免疫疾病中使用"
        },
        {
          "source": "drug_ustekinumab",
          "target": "Phenotype_Gastrointestinal_disorder",
          "relation": "supports",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "针对特定病理机制的治疗"
        },
        {
          "source": "drug_5_aminosalicylic_acid",
          "target": "Phenotype_Gastrointestinal_disorder",
          "relation": "supports",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "用于炎症性肠病的基本治疗"
        },
        {
          "source": "drug_oral_corticosteroids",
          "target": "Phenotype_Gastrointestinal_disorder",
          "relation": "supports",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "常用于急性症状的治疗"
        },
        {
          "source": "n_infliximab",
          "target": "n_ot",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能影响非靶向途径"
        },
        {
          "source": "n_mesalazine",
          "target": "n_ot",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能影响非靶向途径"
        },
        {
          "source": "n_budesonide",
          "target": "n_ot",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能影响非靶向途径"
        },
        {
          "source": "n_azathioprine",
          "target": "n_ot",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能影响非靶向途径"
        },
        {
          "source": "n_adalimumab",
          "target": "n_ot",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能影响非靶向途径"
        },
        {
          "source": "n_tacrolimus",
          "target": "n_ot",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能影响非靶向途径"
        },
        {
          "source": "n_natalizumab",
          "target": "n_ot",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能影响非靶向途径"
        },
        {
          "source": "n_vedolizumab",
          "target": "n_ot",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能影响非靶向途径"
        },
        {
          "source": "n_methotrexate",
          "target": "n_ot",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能影响非靶向途径"
        },
        {
          "source": "n_ustekinumab",
          "target": "n_ot",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能影响非靶向途径"
        },
        {
          "source": "n_aminosalicylic_acid",
          "target": "n_ot",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能影响非靶向途径"
        },
        {
          "source": "n_oral_corticosteroids",
          "target": "n_ot",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能影响非靶向途径"
        },
        {
          "source": "n_ot",
          "target": "n_rp",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "引发潜在风险通路"
        },
        {
          "source": "n_rp",
          "target": "n_adv",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "导致不良表型"
        },
        {
          "source": "n_adv",
          "target": "H1",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "若风险成立，将抵消净获益"
        },
        {
          "source": "n_adv",
          "target": "H2",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "若风险成立，将抵消净获益"
        },
        {
          "source": "n_adv",
          "target": "H3",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "若风险成立，将抵消净获益"
        },
        {
          "source": "n_adv",
          "target": "H4",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "若风险成立，将抵消净获益"
        },
        {
          "source": "n_adv",
          "target": "H5",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "若风险成立，将抵消净获益"
        },
        {
          "source": "n_adv",
          "target": "H6",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "若风险成立，将抵消净获益"
        },
        {
          "source": "n_adv",
          "target": "H7",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "若风险成立，将抵消净获益"
        },
        {
          "source": "n_adv",
          "target": "H8",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "若风险成立，将抵消净获益"
        },
        {
          "source": "n_adv",
          "target": "H9",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "若风险成立，将抵消净获益"
        },
        {
          "source": "n_adv",
          "target": "H10",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "若风险成立，将抵消净获益"
        },
        {
          "source": "n_adv",
          "target": "H11",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "若风险成立，将抵消净获益"
        },
        {
          "source": "n_adv",
          "target": "H12",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "若风险成立，将抵消净获益"
        }
      ],
      "round_index": 2
    },
    "constraints": {
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    }
  },
  "output": {
    "hypothesis_id": "H1",
    "executed_actions": [
      {
        "action_ref": 0,
        "status": "done",
        "graph_updates": {
          "add_nodes": [],
          "add_edges": [
            {
              "source": "drug_infliximab",
              "target": "Phenotype_Gastrointestinal_disorder",
              "relation": "involved_in",
              "weight": 0.85,
              "agent": "Proponent",
              "rationale": "已知用于治疗的药物，具备良好疗效"
            }
          ],
          "merge": [],
          "set_weights": []
        },
        "notes": "成功添加 Infliximab 指向 Gastrointestinal epithelial barrier disorders 的边"
      },
      {
        "action_ref": 1,
        "status": "done",
        "graph_updates": {
          "add_nodes": [],
          "add_edges": [
            {
              "source": "drug_mesalazine",
              "target": "Phenotype_Gastrointestinal_disorder",
              "relation": "involved_in",
              "weight": 0.85,
              "agent": "Proponent",
              "rationale": "相关文献支持其用于此表型"
            }
          ],
          "merge": [],
          "set_weights": []
        },
        "notes": "成功添加 Mesalazine 指向 Gastrointestinal epithelial barrier disorders 的边"
      },
      {
        "action_ref": 2,
        "status": "done",
        "graph_updates": {
          "add_nodes": [],
          "add_edges": [
            {
              "source": "drug_budesonide",
              "target": "Phenotype_Gastrointestinal_disorder",
              "relation": "involved_in",
              "weight": 0.8,
              "agent": "Proponent",
              "rationale": "具有相似用途，临床应用常见"
            }
          ],
          "merge": [],
          "set_weights": []
        },
        "notes": "成功添加 Budesonide 指向 Gastrointestinal epithelial barrier disorders 的边"
      },
      {
        "action_ref": 3,
        "status": "done",
        "graph_updates": {
          "add_nodes": [],
          "add_edges": [
            {
              "source": "drug_azathioprine",
              "target": "Phenotype_Gastrointestinal_disorder",
              "relation": "involved_in",
              "weight": 0.7,
              "agent": "Proponent",
              "rationale": "用于 autoimmune diseases，有潜在益处"
            }
          ],
          "merge": [],
          "set_weights": []
        },
        "notes": "成功添加 Azathioprine 指向 Gastrointestinal epithelial barrier disorders 的边"
      },
      {
        "action_ref": 4,
        "status": "done",
        "graph_updates": {
          "add_nodes": [],
          "add_edges": [
            {
              "source": "drug_adalimumab",
              "target": "Phenotype_Gastrointestinal_disorder",
              "relation": "involved_in",
              "weight": 0.75,
              "agent": "Proponent",
              "rationale": "针对炎症性疾病的靶向药物"
            }
          ],
          "merge": [],
          "set_weights": []
        },
        "notes": "成功添加 Adalimumab 指向 Gastrointestinal epithelial barrier disorders 的边"
      },
      {
        "action_ref": 5,
        "status": "done",
        "graph_updates": {
          "add_nodes": [],
          "add_edges": [
            {
              "source": "drug_tacrolimus",
              "target": "Phenotype_Gastrointestinal_disorder",
              "relation": "involved_in",
              "weight": 0.65,
              "agent": "Proponent",
              "rationale": "免疫抑制剂，可能有治疗潜力"
            }
          ],
          "merge": [],
          "set_weights": []
        },
        "notes": "成功添加 Tacrolimus 指向 Gastrointestinal epithelial barrier disorders 的边"
      },
      {
        "action_ref": 6,
        "status": "done",
        "graph_updates": {
          "add_nodes": [],
          "add_edges": [
            {
              "source": "drug_natalizumab",
              "target": "Phenotype_Gastrointestinal_disorder",
              "relation": "involved_in",
              "weight": 0.55,
              "agent": "Proponent",
              "rationale": "相关研究显示其潜在效果"
            }
          ],
          "merge": [],
          "set_weights": []
        },
        "notes": "成功添加 Natalizumab 指向 Gastrointestinal epithelial barrier disorders 的边"
      },
      {
        "action_ref": 7,
        "status": "done",
        "graph_updates": {
          "add_nodes": [],
          "add_edges": [
            {
              "source": "drug_vedolizumab",
              "target": "Phenotype_Gastrointestinal_disorder",
              "relation": "involved_in",
              "weight": 0.6,
              "agent": "Proponent",
              "rationale": "靶向治疗特定类型的疾病"
            }
          ],
          "merge": [],
          "set_weights": []
        },
        "notes": "成功添加 Vedolizumab 指向 Gastrointestinal epithelial barrier disorders 的边"
      },
      {
        "action_ref": 8,
        "status": "done",
        "graph_updates": {
          "add_nodes": [],
          "add_edges": [
            {
              "source": "drug_methotrexate",
              "target": "Phenotype_Gastrointestinal_disorder",
              "relation": "involved_in",
              "weight": 0.5,
              "agent": "Proponent",
              "rationale": "在自身免疫疾病中使用"
            }
          ],
          "merge": [],
          "set_weights": []
        },
        "notes": "成功添加 Methotrexate 指向 Gastrointestinal epithelial barrier disorders 的边"
      },
      {
        "action_ref": 9,
        "status": "done",
        "graph_updates": {
          "add_nodes": [],
          "add_edges": [
            {
              "source": "drug_ustekinumab",
              "target": "Phenotype_Gastrointestinal_disorder",
              "relation": "involved_in",
              "weight": 0.5,
              "agent": "Proponent",
              "rationale": "针对特定病理机制的治疗"
            }
          ],
          "merge": [],
          "set_weights": []
        },
        "notes": "成功添加 Ustekinumab 指向 Gastrointestinal epithelial barrier disorders 的边"
      },
      {
        "action_ref": 10,
        "status": "done",
        "graph_updates": {
          "add_nodes": [],
          "add_edges": [
            {
              "source": "drug_5_aminosalicylic_acid",
              "target": "Phenotype_Gastrointestinal_disorder",
              "relation": "involved_in",
              "weight": 0.55,
              "agent": "Proponent",
              "rationale": "用于炎症性肠病的基本治疗"
            }
          ],
          "merge": [],
          "set_weights": []
        },
        "notes": "成功添加 5-Aminosalicylic Acid 指向 Gastrointestinal epithelial barrier disorders 的边"
      },
      {
        "action_ref": 11,
        "status": "done",
        "graph_updates": {
          "add_nodes": [],
          "add_edges": [
            {
              "source": "drug_oral_corticosteroids",
              "target": "Phenotype_Gastrointestinal_disorder",
              "relation": "involved_in",
              "weight": 0.6,
              "agent": "Proponent",
              "rationale": "常用于急性症状的治疗"
            }
          ],
          "merge": [],
          "set_weights": []
        },
        "notes": "成功添加 Oral Corticosteroids 指向 Gastrointestinal epithelial barrier disorders 的边"
      }
    ],
    "unexecuted_actions": [],
    "residual_gaps": [
      "仍需验证每种药物的疗效与安全性具体数据"
    ]
  }
}